Trademark: 79246244
Status Date
Tuesday, September 22, 2020
Registration Number
6155634
Registration Date
Tuesday, September 22, 2020
Filing Date
Friday, August 10, 2018
Published for Opposition
Tuesday, July 7, 2020
41 Medical product training for doctors and medical personnel
5 Pharmaceutical substances and preparations in the nature of protein and peptide preparations, in particular for the formation or regeneration of missing or damaged body parts, specifically, parts of the musculoskeletal system, in particular bones; goods of synthetic and natural origin for medical use, in particular consisting of fibrin and polyethylene glycol, for the retention or the delayed release of peptides or proteins, specifically growth factors and hormones which are the substances which stimulate the growth of an organism or maintain it, namely, growth factors and hormones; biomedical and biotechnology products for medical use, namely, orthobiologics that are substances which stimulate the growth or maintenance of musculoskeletal tissues in the nature of growth factors and hormones; orthobiologics for medical use for the permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous musculoskeletal tissues, in particular for bones, intervertebral discs, cartilage, fat and muscle tissues, namely, orthobiologics in the nature of synthetic matrices, growth factors and hormones; permanent and temporary medical adhesives for binding internal tissue compatible with the body, in particular for human or animal organs, soft tissues, and hard tissues for medical use; separation products for medical use compatible with the body, intended to prevent organs and soft parts from sticking together, namely, anti-adhesion products in the nature of anti-adhesion gels for use during and following surgery; modified implants comprising living tissue in endogenous material, tissues, cells and molecules for replacing and assisting the function of missing or damaged body parts; biological endogenous soft tissue, grafts in particular for fat tissue and tissue replacement; biological endogenous hard and soft tissue, grafts in particular for bones for transplantation purposes; natural biomaterials for bone, cartilage, vessel, tissue and fat tissue replacement, namely, biological tissue grafts
44 Medical services provided by a doctor; providing medical advice in the field of orthobiologics, adhesive barriers and tissue sealants
10 Synthetic biomaterials for the substitution of tissue, for the recovery, maintenance and the repair of the function of diseased or damaged human or animal tissue for medical purposes; surgical synthetic implants and modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material; synthetic hard and soft prosthetic tissues, in particular synthetic bone substitution for surgical use in the nature of being for transplantation and diagnostic purposes and for bone, vessel, tissue and fat tissue substitution; modified surgical implants for replacing and assisting with the function of missing or damaged body parts, all comprising artificial material
42 Research and development in the field of biomedicine and biomaterials; engineering services provided by a pharmaceutical or biotechnological company, in particular by a pharmacologist, a biochemist, a scientist specialized in biomaterials or a biotechnologist in the field of tissue engineering; scientific research services for medical use
Oct 13, 2022
International Registration Renewed
Jan 30, 2021
Final Decision Transaction Processed By Ib
Jan 11, 2021
Final Disposition Notice Sent To Ib
Jan 11, 2021
Final Disposition Processed
Dec 22, 2020
Final Disposition Notice Created, To Be Sent To Ib
Sep 22, 2020
Registered-Principal Register
Jul 10, 2020
Notification Processed By Ib
Jul 7, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 7, 2020
Published For Opposition
Jun 17, 2020
Notification Of Possible Opposition Sent To Ib
Jun 17, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 17, 2020
Notification Of Notice Of Publication E-Mailed
Jun 4, 2020
Approved For Pub - Principal Register
May 14, 2020
Teas/Email Correspondence Entered
May 13, 2020
Correspondence Received In Law Office
May 13, 2020
Teas Request For Reconsideration Received
May 8, 2020
Notification Of Possible Opposition - Processed By Ib
Apr 22, 2020
Notification Of Possible Opposition Sent To Ib
Apr 22, 2020
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 18, 2019
Notification Of Subsequent Final Emailed
Nov 18, 2019
Continuation Of Final Refusal E-Mailed
Nov 18, 2019
Action Continuing A Final - Completed
Oct 30, 2019
Teas/Email Correspondence Entered
Oct 30, 2019
Correspondence Received In Law Office
Oct 30, 2019
Teas Request For Reconsideration Received
Jun 17, 2019
Teas Change Of Correspondence Received
Jun 12, 2019
Teas Change Of Correspondence Received
May 2, 2019
Notification Of Final Refusal Emailed
May 2, 2019
Final Refusal E-Mailed
May 2, 2019
Final Refusal Written
Apr 11, 2019
Teas/Email Correspondence Entered
Apr 11, 2019
Correspondence Received In Law Office
Apr 11, 2019
Teas Response To Office Action Received
Mar 20, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 20, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2019
Refusal Processed By Ib
Dec 15, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Dec 15, 2018
Refusal Processed By Mpu
Dec 7, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 6, 2018
Non-Final Action Written
Nov 30, 2018
Application Filing Receipt Mailed
Nov 28, 2018
Assigned To Examiner
Nov 26, 2018
New Application Office Supplied Data Entered In Tram
Nov 22, 2018
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
